Autoimmune diseases

The European Commission ( EC ) has granted marketing authorisation for Olumiant ( Baricitinib ) 4 mg and 2 mg...


Researchers have found early evidence that a common but harmless virus could be behind the celiac disease, by causing the...


Multiple sclerosis is an autoimmune inflammatory neurological disease with complex aetiology where the causes are not completely known. The main...


Women represent nearly 8 out of every 10 people with autoimmune diseases. Although the hugely disproportionate statistics are well known,...


The FDA ( Food and Drug Administration ) has approved Natpara ( Parathyroid hormone ) to control hypocalcemia ( low...


There is strong evidence for an autoimmune etiology of alopecia areata. Interleukin-17A ( IL-17A ) is a Th17 proinflammatory cytokine...


Multiple sclerosis is triggered by self-reactive T cells that successfully infiltrate the brain and spinal cord where they launch an...


Emerging clinical evidence demonstrates high prevalence of QTc prolongation and complex ventricular arrhythmias in patients with anti-Ro antibody ( anti-Ro...


Psoriatic arthritis patients treated with Ixekizumab ( Taltz ) for 24 weeks have achieved significant improvements in signs and symptoms...


The risk of eating disorders has been shown to be increased in some somatic illnesses. Many of these illnesses, such...


Increasing evidence suggests that seizures and status epilepticus can be immune-mediated. Researchers aimed to describe the clinical features of a...


Mavrilimumab and Sifalimumab have met their primary endpoints in respective phase II studies, demonstrating further pipeline progress in core therapeutic...


Guillain-Barre syndrome ( GBS ) is an acute, paralysing, inflammatory peripheral nerve disease. Intravenous immunoglobulin ( IVIg ) is beneficial...


Interim results from the second year of the extension study of Alemtuzumab ( Lemtrada ) for multiple sclerosis were presented...


Idiopathic membranous nephropathy is an autoimmune disease. In approximately 70% of patients, it is associated with autoantibodies against the phospholipase...


There is an increased risk of tuberculosis, or reactivation of latent tuberculosis, during treatment with tumour necrosis factor alpha (...


A phase 1 clinical trial for the first treatment to reset the immune system of multiple sclerosis patients has showed...


The immune system is composed of numerous interacting cell populations with distinct functions. As for any system, it is (...


Rheumatoid arthritis is the most common inflammatory arthritis, affecting 0.5% to 1% of the general population worldwide.The current pharmacological management...


Eli Lilly and Incyte have announced 52-week efficacy and safety data from the open-label, long-term extension of the Phase 2b...